0001209191-17-026567.txt : 20170411
0001209191-17-026567.hdr.sgml : 20170411
20170411161928
ACCESSION NUMBER: 0001209191-17-026567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170410
FILED AS OF DATE: 20170411
DATE AS OF CHANGE: 20170411
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siegel Eric H.
CENTRAL INDEX KEY: 0001527573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 17756113
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY RD., BLDG. E336
STREET 2: C/O INCYTE CORP., EXPERIMENTAL STATION
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-10
0
0000879169
INCYTE CORP
INCY
0001527573
Siegel Eric H.
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, General Counsel
Common Stock
2017-04-10
4
M
0
2223
18.32
A
19008
D
Common Stock
2017-04-10
4
M
0
1820
64.55
A
20828
D
Common Stock
2017-04-10
4
S
0
2223
140.18
D
18605
D
Common Stock
2017-04-10
4
S
0
1820
140.18
D
16785
D
Non-Qualified Stock Option (right to buy)
18.32
2017-04-10
4
M
0
2223
0.00
D
2020-02-08
Common Stock
2223
0
D
Non-Qualified Stock Option (right to buy)
64.55
2017-04-10
4
M
0
1820
0.00
D
2021-01-20
Common Stock
1820
22032
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Eric Siegel
2017-04-11